© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
FDA Approves Delgocitinib, First Treatment for Adults With Moderate to Severe Chronic Hand Eczema
July 24, 2025
The nonsteroidal topical pan-JAK inhibitor provides a potent treatment option for adults with CHE who have not responded to corticosteroids or cannot tolerate them.
The Weekly Dose: Insights on Atopic Dermatitis, Menopause Care, Cancer Screening, and Weight Loss Therapy
July 23, 2025
Insights on an FDA-approved multi-cancer detection test, the impact of obesity pharmacotherapy adherence on weight loss outcomes, and more.
Refined Digital Tools Have Revolutionized the Return on Cognitive Screening: Investigator Rodney Swenson, PhD, Explains
July 23, 2025
Swenson focused on the precision afforded by digital tools in assessing human behavior and identifying preclinical signs of cognitive impairment.
Muscle Loss During GLP-1 Therapy Top Concern for Patients Using the Antiobesity Medications
July 23, 2025
Individuals on GLP-1 therapy express significant concern about muscle loss, prompting lifestyle changes and highlighting the need for informed primary care guidance.
Obesity and Cardiovascular Disease Management: 3 Pearls for Primary Care
July 23, 2025
Monu Khanna, MD, offers 3 takeaways for primary care: address obesity as root cause, reduce stigma, and explore new treatments to reduce cardiovascular risk.
Efficacy of Apnimed's Novel Oral Formulation Targeting OSA Confirmed in Second Phase 3 Trial
July 23, 2025
Apnimed's first-in-class anti-apneic AD109 increases upper airway muscle tone during sleep; the company plans to file an NDA with the FDA in early 2026.
Obesity Is a Chronic Disease—Start the Conversation in Primary Care, Says Monu Khanna, MD
July 22, 2025
Dr Khanna discusses why obesity should be treated as a chronic disease in primary care and how early conversations can help prevent cardiometabolic complications.
What is Driving Type 2 Diabetes in the US?
July 22, 2025
Type 2 diabetes and its high and rising rates in the US are the result of a perfect storm of converging systemic, behavioral, environmental, and economic factors.
AAIC 2025 to Feature Lecanemab Data on Long-Term Efficacy, Real-World Use, and Maintenance Dosing
July 22, 2025
Eisai will present four-year safety and efficacy data, real-world use patterns, and findings on a new subcutaneous formulation for maintenance treatment in early Alzheimer disease.
Why Cognitive Screening Should Be Routine in Primary Care: A Conversation With Anna Chodos, MD, MPH
July 22, 2025
In recognition of World Brain Day, Anna Chodos, MD, discusses why early detection of cognitive decline must become standard practice—and how PCPs can take simple, effective steps to make that happen.